Nerome Kuniaki, Matsuda Sayaka, Maegawa Kenichi, Sugita Shigeo, Kuroda Kazumichi, Kawasaki Kazunori, Nerome Reiko
The Institute of Biological Resources, 893-2, Nakayama, Nago, Okinawa 905-0004, Japan.
The Institute of Biological Resources, 893-2, Nakayama, Nago, Okinawa 905-0004, Japan.
Vaccine. 2017 Feb 1;35(5):738-746. doi: 10.1016/j.vaccine.2016.12.058. Epub 2017 Jan 5.
In this study, we aimed to quantitatively compare the increased production of three H7 influenza virus-like particle (VLP) haemagglutinin (HA) with the use of a codon-optimized single HA gene in silkworm pupae. Recombinant baculovirus (Korea H7-BmNPV) could produce 0.40 million HA units per pupa, corresponding to 1832μg protein. The yield of the HA produced in larva was estimated to be approximately 0.31 million HA units per larva, and there were no significant differences between the three HA proteins. We could establish efficient recovery system of HA production in larvae and pupae with the use of three cycles sonication methods. Next, we compared yields of HA proteins from three different H7 and two H5 recombinant baculoviruses based on the amount of mRNA synthesized in BmN cells, suggesting that mRNA synthesis may be also a useful indicator for the production of HA. Based on HA titres from four recombinants, the yield of HA had a great influence on the codon-optimized effect and the characteristics of the viral HA gene. The recombinant containing codon optimized HA DNA of A/tufted duck/Fukushima/16/2011 (H5N1) did produce more than one million HA units, although another recombinant including of the wild H5N1 strain failed to show HA activity. Electron microscopy revealed the presence of large VLP and small HA particle in the heavy and light fractions. The purified VLPs reacted with the authentic anti-H7 antibodies and the antibodies prepared after immunization with the VLP H7 antigen. Also H5 and H7VLPs could produce HI antibody in chickens and mice with oral immunization. The antibodies elicited with oral immunization were confirmed in fluorescent antibody analysis and western blotting in Korea H5-BmNPV and H7HA-BmNPV recombinant infected BmN cells. Taken together, these findings provided important insights into future oral vaccine development.
在本研究中,我们旨在定量比较在蚕蛹中使用密码子优化的单个血凝素(HA)基因时三种H7流感病毒样颗粒(VLP)血凝素(HA)产量的增加情况。重组杆状病毒(韩国H7 - BmNPV)每个蛹可产生40万个HA单位,相当于1832μg蛋白质。幼虫中产生的HA产量估计约为每个幼虫31万个HA单位,三种HA蛋白之间无显著差异。我们可以通过使用三轮超声处理方法建立幼虫和蛹中HA生产的高效回收系统。接下来,我们根据在BmN细胞中合成的mRNA量,比较了三种不同H7和两种H5重组杆状病毒产生的HA蛋白产量,这表明mRNA合成也可能是HA生产的一个有用指标。基于四种重组体的HA滴度,HA产量对密码子优化效果和病毒HA基因的特性有很大影响。含有A/簇羽鸭/福岛/16/2011(H5N1)密码子优化HA DNA的重组体确实产生了超过100万个HA单位,尽管另一个包含野生H5N1株的重组体未能显示出HA活性。电子显微镜显示在重馏分和轻馏分中存在大的VLP和小的HA颗粒。纯化的VLP与正宗的抗H7抗体以及用VLP H7抗原免疫后制备的抗体发生反应。此外,H5和H7 VLP通过口服免疫可在鸡和小鼠中产生血凝抑制(HI)抗体。在韩国H5 - BmNPV和H7HA - BmNPV重组体感染的BmN细胞中,通过荧光抗体分析和蛋白质印迹法证实了口服免疫引发的抗体。综上所述,这些发现为未来口服疫苗的开发提供了重要的见解。